Atopic Dermatitis Clinical Trials in Savannah, Georgia

4 studies are recruiting for atopic dermatitis in Savannah, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

    The purpose of the study is to evaluate the dose-response relationship of galvokimig compared with placebo in study participants with moderate-to-severe atopic dermatitis (AtD).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Atd002 52015, Savannah, Georgia
    Locations
    68 in total
    Run by
    UCB Biopharma SRL

    See if you can join NCT07277660 on ClinicalTrials.gov

  2. A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

    This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    Georgia Skin & Cancer Center, Savannah, Georgia
    Locations
    85 in total
    Run by
    Apollo Therapeutics Ltd

    See if you can join NCT07599813 on ClinicalTrials.gov

  3. A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

    Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Topical therapies applied over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study compares upadacitinib to dupil…

    Stage
    Phase 3
    Ages
    2 to 11
    Site
    Aeroallergy Research Laboratory /ID# 267247, Savannah, Georgia
    Locations
    150 in total
    Run by
    AbbVie

    See if you can join NCT06461897 on ClinicalTrials.gov

  4. A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

    Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study aims to provide data on the efficacy an…

    Stage
    Phase 3
    Ages
    18 to 63
    Site
    Georgia Skin & Cancer Clinic /ID# 267199, Savannah, Georgia
    Locations
    128 in total
    Run by
    AbbVie

    See if you can join NCT06389136 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.